Literature DB >> 3490201

Auditory and temporal bone abnormalities in CHARGE association.

C G Wright, O E Brown, W L Meyerhoff, J C Rutledge.   

Abstract

CHARGE association is a recently described cluster of congenital defects including ocular coloboma, heart disease, choanal atresia, retarded development and/or CNS abnormalities, genital hypoplasia, and ear anomalies. Although congenital hearing loss has been reported in CHARGE association, no information regarding the underlying temporal bone disease is available in the literature to date. The authors evaluated four patients with multiple anomalies consistent with CHARGE syndrome. Two surviving patients have bilateral severe hearing loss on auditory brain stem response testing. Two patients did not survive, and their temporal bones were obtained at autopsy for histologic examination. All four temporal bones showed severe middle ear defects including ossicular deformities, absence of the stapedius muscle, absence of the oval window, aberrant course of the facial nerve, and dehiscence of the facial nerve canal. In the more severely affected case, a Mondini-type malformation of the cochlea was present, together with multiple anomalies of the vestibular apparatus. Vestibular defects also occurred in the other case; however, the cochleae were found to be normally developed.

Entities:  

Mesh:

Year:  1986        PMID: 3490201     DOI: 10.1177/000348948609500509

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  10 in total

1.  Absent semicircular canals in CHARGE syndrome: radiologic spectrum of findings.

Authors:  A K Morimoto; R H Wiggins; P A Hudgins; G L Hedlund; B Hamilton; S K Mukherji; S A Telian; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Bilateral posterior semicircular canal aplasia and atypical paroxysmal positional vertigo: a case report.

Authors:  L E Walther; V Nath; G A Krombach; E Di Martino
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-04       Impact factor: 2.124

3.  Mature middle and inner ears express Chd7 and exhibit distinctive pathologies in a mouse model of CHARGE syndrome.

Authors:  Elizabeth A Hurd; Meredith E Adams; Wanda S Layman; Donald L Swiderski; Lisa A Beyer; Karin E Halsey; Jennifer M Benson; Tzy-Wen Gong; David F Dolan; Yehoash Raphael; Donna M Martin
Journal:  Hear Res       Date:  2011-08-23       Impact factor: 3.208

4.  Growth failure and pituitary function in CHARGE and VATER associations.

Authors:  V V Khadilkar; F J Cameron; R Stanhope
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

Review 5.  Cochlear histopathology in human genetic hearing loss: State of the science and future prospects.

Authors:  Krishna Bommakanti; Janani S Iyer; Konstantina M Stankovic
Journal:  Hear Res       Date:  2019-08-19       Impact factor: 3.208

Review 6.  Congenital hearing impairment.

Authors:  Caroline D Robson
Journal:  Pediatr Radiol       Date:  2006-02-08

7.  Cochlear Implants in Children Diagnosed with CHARGE Syndrome.

Authors:  Carolina Costa Cardoso; Michelle Sales de Meneses; Isabella Monteiro de Castro Silva; Angela Maria Vaccaro Silva Alves
Journal:  Int Arch Otorhinolaryngol       Date:  2013-10

8.  Implementing the chick embryo model to study vestibular developmental disorders.

Authors:  Hayley E Seal; Sigmund J Lilian; Anastas Popratiloff; June C Hirsch; Kenna D Peusner
Journal:  J Neurophysiol       Date:  2019-10-02       Impact factor: 2.714

9.  Outcomes of long-term audiological rehabilitation in charge syndrome.

Authors:  P Trevisi; A Ciorba; C Aimoni; R Bovo; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-06       Impact factor: 2.124

Review 10.  Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions.

Authors:  Kenna D Peusner; Nina M Bell; June C Hirsch; Mathieu Beraneck; Anastas Popratiloff
Journal:  Front Neurol       Date:  2021-09-10       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.